CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 310 filers reported holding CRISPR THERAPEUTICS AG in Q3 2020. The put-call ratio across all filers is 1.02 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $856,782 | -19.1% | 18,876 | 0.0% | 0.07% | -22.5% |
Q2 2023 | $1,059,699 | +24.1% | 18,876 | 0.0% | 0.09% | -1.1% |
Q1 2023 | $853,761 | +11.3% | 18,876 | 0.0% | 0.09% | +36.4% |
Q4 2022 | $767,309 | -37.8% | 18,876 | 0.0% | 0.07% | -41.1% |
Q3 2022 | $1,234,000 | +7.6% | 18,876 | 0.0% | 0.11% | +20.4% |
Q2 2022 | $1,147,000 | -3.2% | 18,876 | 0.0% | 0.09% | +60.3% |
Q1 2022 | $1,185,000 | -17.1% | 18,876 | 0.0% | 0.06% | -49.1% |
Q4 2021 | $1,430,000 | -32.3% | 18,876 | 0.0% | 0.11% | -49.1% |
Q3 2021 | $2,113,000 | -30.9% | 18,876 | 0.0% | 0.22% | -25.6% |
Q2 2021 | $3,056,000 | +32.9% | 18,876 | 0.0% | 0.30% | +26.5% |
Q1 2021 | $2,300,000 | -24.3% | 18,876 | -4.9% | 0.24% | -24.4% |
Q4 2020 | $3,038,000 | +83.1% | 19,840 | 0.0% | 0.32% | +76.0% |
Q3 2020 | $1,659,000 | +13.8% | 19,840 | 0.0% | 0.18% | 0.0% |
Q2 2020 | $1,458,000 | +47.9% | 19,840 | -14.7% | 0.18% | +65.7% |
Q1 2020 | $986,000 | -33.7% | 23,252 | -4.8% | 0.11% | -15.0% |
Q4 2019 | $1,487,000 | +48.6% | 24,420 | 0.0% | 0.13% | +62.8% |
Q3 2019 | $1,001,000 | -21.6% | 24,420 | -9.9% | 0.08% | -6.0% |
Q2 2019 | $1,277,000 | +17.9% | 27,112 | -10.6% | 0.08% | +25.8% |
Q1 2019 | $1,083,000 | +10.2% | 30,316 | -11.9% | 0.07% | +37.5% |
Q4 2018 | $983,000 | -61.1% | 34,397 | -39.7% | 0.05% | -42.2% |
Q3 2018 | $2,528,000 | -24.5% | 57,000 | 0.0% | 0.08% | -11.7% |
Q2 2018 | $3,349,000 | – | 57,000 | – | 0.09% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 498,558 | $31,294,000 | 31.24% |
NEA Management Company, LLC | 1,590,002 | $365,593,000 | 10.56% |
Ariose Capital Management Ltd | 37,900 | $2,379,000 | 9.30% |
ARK Investment Management | 9,404,071 | $590,294,000 | 2.46% |
NIA IMPACT ADVISORS, LLC | 80,082 | $5,027,000 | 2.44% |
Nikko Asset Management Americas, Inc. | 4,619,747 | $291,044,000 | 2.14% |
PLUSTICK MANAGEMENT LLC | 50,000 | $3,139,000 | 1.98% |
Integral Health Asset Management, LLC | 120,000 | $7,532,000 | 1.96% |
Valiant Capital Management, L.P. | 240,683 | $15,108,000 | 1.73% |
Deuterium Capital Management, LLC | 18,000 | $1,130,000 | 1.45% |